- Diffuse large B-cell lymphoma is a serious blood cancer.
- The usual treatment uses an antibody and chemotherapy.
- This treatment helps many patients but not all.
- Chemotherapy can damage the heart in older people.
- Researchers studied pet dogs with the same cancer.
- Dogs received an antibody and low-dose chemotherapy.
- Scientists measured gene activity in the blood.
- They found two genes linked to longer survival.
- A simple blood test can detect early warning genes.
- Doctors may use the test to choose better treatment.
Difficult words
- lymphoma — a serious cancer that affects the blood
- antibody — a protein the body makes to fight germs
- chemotherapy — medicine that kills cancer cells in the body
- measure — to check or record a number or valuemeasured
- gene — a small part of DNA with instructionsgenes
- survival — the act of living after a disease or danger
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you have a pet dog?
- Would you take a blood test if a doctor asked?
- Do you know anyone who had chemotherapy?
Related articles
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Wearable 10‑Minute Antibody Sensors from University of Pittsburgh
Researchers at the University of Pittsburgh made a wearable biosensor that detects antibodies in interstitial fluid in 10 minutes without a blood draw. The tiny carbon nanotube sensors are highly sensitive and the work appears in Analytical Chemistry.
Hantavirus linked to international cruise ship
WHO reports 11 hantavirus cases, including three deaths, connected to the Dutch-flagged MV Hondius that sailed from Argentina to Cape Verde. Some passengers later travelled through South Africa; health authorities say public risk remains low.
African leaders call for local funding of medical innovation
A group of African science leaders says Africa must develop and pay for its own medical innovations to improve health and rely less on uncertain international funding. They call for more national investment, reforms and stronger research systems.